Clinical Trial Update: Clinical and Molecular Effects of N-Acetylcysteine Treatment in COVID-19-Related Acute Respiratory Distress Syndrome [NA]

View source ↗

Summary

A completed clinical trial from the University of Gaziantep assessed the clinical and molecular effects of N-acetylcysteine in COVID-19–associated acute respira…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University of Gaziantep | Conditions: COVID-19-Associated Acute Respiratory Distress Syndrome (ARDS) | NA | Status: COMPLETED